Covid-19 Brazil

Brazil’s Butantan aims to supply 40 million doses of its own Covid-19 vaccine by year-end

By Latin America News · May 27, 2021 · 1 min read

RIO DE JANEIRO, BRAZIL – (REUTERS) Brazil’s Butantan Institute could supply at least 40 million doses of its own Covid-19 vaccine, called ButanVac, in the fourth quarter of 2021, said Director Dimas Covas on Thursday, May 27.

Speaking before a Senate panel investigating the federal government’s handling of the pandemic, Covas said clinical trials of the new vaccine can be concluded quickly, though they still need to be authorized by Brazilian health regulator ANVISA.

More: Brazil news in English, every day from The Rio Times.

Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error

The Rio Times · Power Map

See who really holds power in Latin America

Click to open the Power Map →

Brazil’s Butantan aims to supply 40 million doses of its own Covid-19 vaccine by year-end

The LatAm Brief

Rotate for Best Experience

You've reached your free article limit